GLG News Analyses of the following article:
Portola inks potential $470M Merck deal
Published at: www.bizjournals.com
-
Small Players Will the Pharma Band Wagon
July 10, 2009
Portola Merck deal is the indication of way things are currently in Global Pharma Industry. Big Pharma have virtually stopped innovating, and even if they do their costs are not sustainable. Portola and companies like Portola are the future of pharma innovation. Its going to be a case of "Tail wagging the Dog" undefined
- Subscribe to Updates
-
Work for one of the world's leading organizations? Get started now.
Get Intelligently Connected
with the world's leading experts
GLG's 850+ Clients Include:
- More than 70% of the world's leading
- mutual funds
- 15 of the leading 20
- global banks
- 9 of the leading 10
- global private equity firms
- 5 of the leading 10
- AmLaw firms
- Fortune 500® Companies
- in nearly every industry sector, including pharmaceuticals, insurance, chemicals, energy and computer software
Gerson Lehrman Group, Inc. connects communities with knowledge through two distinct, yet complementary offerings: GLG Research and G+.